Comparing two types of nerve blocks for pain relief in obese patients
Ultrasound-Guided Erector Spinae Plane Block Versus Modified Thoracoabdominal Nerve Block for Perioperative Analgesia in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy. A Randomized Comparative Trial
This study is testing two different nerve block methods to see which one helps obese patients feel less pain after surgery while using fewer opioids.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Kasr El Aini Hospital Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06841783 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of two different nerve block techniques, the ultrasound-guided erector spinae plane block (ESPB) and the modified thoracoabdominal nerve block (M-TAPA), for managing postoperative pain in patients with morbid obesity. Patients will be randomly assigned to receive one of the two nerve blocks prior to surgery, and their pain levels will be assessed using a visual analog scale (VAS) postoperatively. The study seeks to reduce reliance on opioids for pain management, aligning with Enhanced Recovery after Surgery (ERAS) guidelines. Comprehensive preoperative assessments will be conducted to ensure patient safety and suitability for the procedures.
Who should consider this trial
Good fit: Ideal candidates for this study are obese patients aged 18 to 65 with ASA II or ASA III classifications.
Not a fit: Patients who are uncooperative, have allergies to local anesthetics, or have anatomical abnormalities at the injection site may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a safer and more effective pain management strategy for obese patients undergoing surgery.
How similar studies have performed: While nerve blocks for pain management are common, this specific comparison of ESPB and M-TAPA in morbidly obese patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1. ASA II \& ASA III. 2. Gender both males and females 3. Age group: from 18 to 65 years old Exclusion Criteria: * • Patient refusal. * Uncooperative patients. * Allergy to local anesthetics. * Anatomical abnormality at injection site. * Redo or combined cholecystectomy surgery. * Infection at injection site.
Where this trial is running
Cairo
- Kasr Alainy — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: ahmed nabih, lecturer
- Email: nabihomar100@yahoo.com
- Phone: 01002773488
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.